From the Podcast : A Turning Point for Biologicals in Europe

Share This Article

A Conversation with Karel Bolckmans

December 2025 marks a momentous occasion that many have been anticipating for a long time. To discuss the recent developments in the EU, I spoke with Karel Bolckmans, president of IBMA. This discussion is particularly important from IBMA’s perspective. European farmers have long struggled to access truly sustainable crop protection solutions, especially as chemical alternatives are increasingly restricted. This gap has left farmers with significant challenges in managing their crops. With European agriculture at a crucial crossroads, it is important to reflect on the challenges faced and the steps being taken toward a long-term solution.
Karel Bolckmans

Karel exclaimed this was a moment of celebration. He shared that IBMA started 30 years ago with the goal of advocating for a more proportionate regulatory environment for biologicals in Europe and globally. Currently, it takes 7 to 10 years to register a new biological control product in Europe—an unreasonably long process. By comparison, it takes 3–4 years in most other regions and just 1–2 years in Brazil.

As a result, European farmers lag in access to sustainable crop protection solutions. At the same time, chemical pesticides are being rapidly removed from the market through the 10-year reauthorization process. This mismatch—slow access to biologicals versus fast removal of chemicals—is leaving farmers with fewer tools to manage pests and diseases, which could eventually threaten food security in Europe. The current regulatory framework has also stifled innovation. European biocontrol companies are increasingly investing and launching products outside Europe, while biocontrol flourishes elsewhere.

He explained that the European Commission’s recent proposal aims to change this. Although it is still subject to approval by the European Parliament and the Council of Agriculture Ministers, it represents a historic first step toward a more balanced regulatory system. The proposal is not perfect, but if implemented, December 16, 2025, could be remembered as a landmark day for biocontrol in Europe.

Roger Tripathi

I feel the challenges faced by European farmers are often underestimated. These include not only the phasing out of certain chemical products but also the issue of resistance. Complicating matters further, the same chemicals remain permitted in neighboring countries that supply produce to Europe, limiting the effectiveness of these restrictions for European farmers. This underscores the urgent need for alternative solutions. Regarding the recent historic declaration, what are its main elements? What makes this day transformative for European agriculture and the biocontrol industry?

Karel Bolckmans

Karel explained that the European Commission’s proposal is part of a larger simplification package, a comprehensive 101-page document addressing ten different European regulations across areas related to food and feed. One of the key regulations within this package is EC 1107/2009, which governs plant protection products. Let us focus on that.

From the very first page, the Commission acknowledges the problem clearly: the current regulatory process takes too long, creating challenges for farmers. Immediate action is needed to ensure farmers can continue to control pests and diseases, while also supporting a transition to more sustainable agriculture, particularly in crop protection.

The Commission identifies the core issue: the slow regulatory process is largely due to insufficient resources and expertise at the European Food Safety Authority (EFSA) and within member states. Many evaluators at the member state level are highly experienced with chemical pesticides, but when presented with a biological product dossier, they often struggle. This leads to repeated questions and delays, sometimes stretching the process over a decade. It is fundamentally a resource, competency, and skills issue.

To address this, the Commission proposes three main approaches:

  1. Reinforce EFSA: Increase resources, skills, and expertise to strengthen EFSA’s ability to evaluate biological products efficiently.
  2. Support member states: For countries lacking sufficient expertise, EFSA can provide assistance in evaluating biological product registration applications.
  3. Use existing resources more efficiently through five measures.

The 5 Key Efficiency Measures

  • 1. Eliminate automatic 10-year renewals: Re-evaluations for biologicals would only occur if new scientific information indicates potential risks, freeing resources for new dossiers.
  • 2. Priority lane: Evaluations of biologicals will be prioritized.
  • 3. Mutual recognition: If a few countries evaluate a product and deem it safe, other member states will automatically recognize the evaluation after 120 days.
  • 4. Provisional authorization: Products can receive provisional approval before full evaluation, accelerating market access.
  • 5. Single zone for biologicals: Evaluating biologicals across a single European zone rather than three climate zones.

Karel summarized, these five measures are designed to make the evaluation of biological control products faster, more efficient, and more effective.

Roger Tripathi

A question arises in my mind from the way it was phrased: “if and when it is approved.” What are the reasons for that caution, and what can the industry do to ensure approval by the European Parliament and the Council of Ministers? This progress is significant, and the measures in the document are grounded in common sense, so understanding why uncertainty remains is important.

Karel Bolckmans

Karel underlined that the timing of approval—if and when it happens—depends on multiple factors, and all stakeholders share responsibility, including the industry and individual companies. The speed of the registration process is directly influenced by the quality of the application dossier submitted. If a dossier is poorly prepared, it is no surprise that authorities will ask additional questions, extending the overall process. In other words, we also bear responsibility for ensuring high-quality submissions.

Roger Tripathi

As I had mentioned, this is still a proposal that must be approved by the European Parliament and the Council of Ministers, a process expected to take one to two years. I am wondering if there is any indication of opposition, reluctance, or self-interest from certain groups that could slow down this approval process?

Karel Bolckmans

Karel highlighted that some parts of the proposal also affect chemical pesticides, which has made them quite controversial. As reported in the press, many NGOs argue that the Commission is using biologicals as a “Trojan horse” to deregulate chemical pesticides. Let me clarify the facts.

First, the 10-year automatic renewal process will no longer apply to chemical pesticides. However, the proposal still requires an immediate re-evaluation if new scientific information indicates that a chemical or biological product is less safe than initially assessed. This is not a complete deregulation.

The second controversial element concerns grace periods for products removed from the market. Under the proposal, these periods would double: one year for sales and three years for stock usage. These two changes are the primary points of contention for NGOs.

The NGO Dialogue:
“As IBMA, our focus remains on promoting biologicals rather than engaging in activism. Our approach is to advance sustainable agriculture by developing new alternative solutions.”
Roger Tripathi

I feel that the concerns in the media can sometimes amplify fears and risk derailing the process… Alignment among all stakeholders is already underway, but are there plans to engage NGOs to foster better understanding?

Karel Bolckmans

Karel mentioned that extending the grace period is intended solely to protect existing stocks and allow more time to transition to alternative biocontrol products… We have emphasized that this is a delicate situation—we must be careful not to “throw the baby out with the bathwater.” The greatest risk is that the process gets derailed… We all know that creating and approving a new regulation can take years, sometimes up to a decade.

At this moment, the European Commission is extending a hand. After 30 years, they are saying: “Let us help you.” It is not perfect, but it is significant and will have a substantial positive impact. We should take that hand, celebrate this progress, and make it happen.

Roger Tripathi

I agree this is indeed a delicate subject… The bottom line is, let us not distract or confuse at the moment. Our focus should be on the simplification so we can get our farmers some relief with immediate effect, and then we all, collectively as a team, talk about the new regulation.

Karel Bolckmans

He mentioned that the proposal is not perfect, but it is good enough. There are two aspects of the proposal that we struggle with, and it is important for the audience to understand them.

1. Registration Timeline: The Commission’s proposal does not set a clear target. It is open-ended. Europe should be ambitious and aim for two to three years.

2. Definition of Biologicals: The proposal specifies that products must be “structurally similar and functionally identical” to naturally occurring compounds. If interpreted literally, modified natural products—strobilurins, avermectins, spinosyns, pyrethroids—could be classified as biologicals. This would dilute the meaning of biocontrol.

Roger Tripathi

When we are discussing innovation, it is crucial not to make definitions overly restrictive… The efforts from IBMA’s presidency and the broader industry to bring stakeholders together help align goals and ensure a unified approach.

Karel Bolckmans

Karel exclaimed that this is a moment of celebration. It feels like a wonderful Christmas present for all of us… The second point is the importance of unity within our industry. For companies not yet members of IBMA, I encourage you to join.

Now, more than ever, it is critical to stand together. 2026 promises to be a very important year—perhaps one of the most significant in the history of biological control. Being united will ensure that our industry continues to advance and have influence where it matters most.

Roger Tripathi

I feel this is not about publicity. IBMA stands out as one of the strongest, if not the strongest, industry associations in terms of contributions to both European and international interests… I sincerely thank Karel for this amazing conversation and insights into the latest developments.

Join the Movement: IBMA Membership is open to startups and established players alike.

Leave a Reply

Your email address will not be published. Required fields are marked *

Beyond Representation: Global BioAg Alliance Advancing Women’s Leadership

Share This Article Creating Space, Voice, and Leadership for the Future of BioAg by Nishant…

Read More

Women in BioAg: Leadership, Innovation and the Road to Equity

Share This Article Insights from the Women Leaders & Entrepreneurs at the 6th BioAgTech World…

Read More

Global BioAg Alliance (GBA): A Unified Global Effort to Shape the Future of BioAg

Share This Article Global BioAg Alliance (GBA) Officially Launches by Nishant Malhotra As the global…

Read More

Driving into 2026: Regulatory Choices Facing European Agriculture

Share This Article Happy New Year! Are You Traveling by Car or by (Omni)bus in…

Read More

From the Podcast : A Turning Point for Biologicals in Europe

Share This Article A Conversation with Karel Bolckmans President, IBMA • By Roger Tripathi, Editor-in-Chief,…

Read More

From Bottleneck to Breakthrough: Unlocking Biocontrol in Europe

Share This Article IBMA Champions Regulatory Reform to Deliver Innovation to Farmers Faster by Sulakshna…

Read More